December 7, 2022 ATLANTA — Visioneering Technologies Inc.’s PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study has officially reached 100% participant enrollment....
sponsored content August 1, 2022 By Ashley Tuan, OD, PhD, FAAO Randomized controlled chicken studies have shown relative myopic defocus from a...
May 20, 2022 COSTA MESA, Calif. — THE Myopia Meeting is back in person and returned with an all-day event here Sunday,...
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...
February 17, 2021 ATLANTA – Visioneering Technologies, Inc. (VTI) has received investment commitments of $22 million, according to a company announcement. Capital...